Fifth Third Bancorp’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-19
Closed -$433 2758
2023
Q1
$433 Buy
+19
New +$489 ﹤0.01% 2712
2022
Q3
Sell
-21
Closed -$1K 2746
2022
Q2
$1K Buy
+21
New +$814 ﹤0.01% 2585
2021
Q4
Sell
-8
Closed 2792
2021
Q3
$0 Buy
+8
New +$444 ﹤0.01% 2746
2016
Q1
Sell
-36
Closed -$1K 2649
2015
Q4
$1K Hold
36
﹤0.01% 2646
2015
Q3
$1K Buy
36
+12
+50% +$282 ﹤0.01% 2781
2015
Q2
$1K Buy
24
+1
+4% +$25 ﹤0.01% 2759
2015
Q1
$1K Buy
+23
New +$548 ﹤0.01% 2665

Other funds holding SRDX

Fifth Third Bancorp's SRDX Position: Q2 2023 in Review

Fifth Third Bancorp sold out of Surmodics (SRDX) in Q2 2023, closing a stake of 19 shares — an estimated $433 sold.

Fifth Third Bancorp first reported a position in SRDX in Q1 2015 and held it in 7 quarters. The position peaked at $1K in Q2 2022. 105 funds tracked by Wall St. Rank hold SRDX as of Q2 2023.

  • Fifth Third Bancorp reported no remaining Surmodics position as of Q2 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 19 Surmodics shares in Q2 2023, an estimated $433.
  • Fifth Third Bancorp first reported a position in Surmodics in Q1 2015 and held it in 7 quarters.
  • Fifth Third Bancorp's Surmodics position peaked at $1K in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Surmodics as of Q2 2023.

Based on Fifth Third Bancorp's 13F filing for Q2 2023, filed 26 Jul 2023.